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Abstract
Introduction The use of moderate hypothermia during
experimental cardiac surgery is associated with decreased
expression of tumour necrosis factor (TNF)-α in myocardium
and with myocardial protection. In order to identify the cellular
mechanisms that lead to that repression, we investigated the
effect of hypothermia during cardiac surgery on both main
signalling pathways involved in systemic inflammation, namely
the nuclear factor-κB (NF-κB) and activating protein-1
pathways.
Method Twelve female pigs were randomly subjected to
standardized cardiopulmonary bypass with moderate
hypothermia or normothermia (temperature 28°C and 37°C,
respectively; six pigs in each group). Myocardial probes were
sampled from the right ventricle before, during and 6 hours after
bypass. We detected mRNA encoding TNF-α by competitive
RT-PCR and measured protein levels of TNF-α, inducible nitric
oxide synthase and cyclo-oxygenase-2 by Western blotting.
Finally, we assessed the activation of NF-κB and activating
protein-1, as well as phosphorylation of p38 mitogen-activated
protein kinase by electrophoretic mobility shift assay with super
shift and/or Western blot.
Results During and after cardiac surgery, animals subjected to
hypothermia exhibited lower expression of TNF-α and cyclo-
oxygenase-2 but not of inducible nitric oxide synthase. This was
associated with lower activation of p38 mitogen-activated
protein kinase and of its downstream effector activating protein-
1 in hypothermic animals. In contrast, NF-κB activity was no
different between groups.
Conclusion These findings indicate that the repression of TNF-
α associated with moderate hypothermia during cardiac surgery
is associated with inhibition of the mitogen-activated protein
kinase p38/activating protein-1 pathway and not with inhibition
of NF-κB. The use of moderate hypothermia during cardiac
surgery may mitigate the perioperative systemic inflammatory
response and its complications.
Introduction
Myocardial damage is an important complication of cardiac
surgery involving cardiopulmonary bypass (CPB) [1]. Synthe-
sis of tumour necrosis factor (TNF)-α in the myocardium is
thought to play a central role in its pathophysiology [2,3].
Indeed, there is a large body of evidence that, in experimental
models, over-expression of TNF-α in the myocardium is related
to adverse cardiac effects such as postinfarct remodelling and
ventricular dilatation [4], transition from hypertrophic to dilated
cardiomyopathy due to apoptosis [5] and impaired postis-
chaemic functional recovery [6]. Additionally, local administra-
tion of soluble TNF-α receptor-1 gene reduced infarct size in
a model of ischaemia/reperfusion injury [7]. In a study con-
ducted in a neonatal model of ischaemia of the hypertrophied
left ventricle, inhibition of the biological activity of TNF-α signif-
icantly improved postischaemic contractile function, myocar-
AP = activating protein; COX = cyclo-oxygenase; CPB = cardiopulmonary bypass; IκB = NF-κB inhibitory protein; iNOS = inducible nitric oxide syn-
thase; MAPK = mitogen-activated protein kinase; NF-κB = nuclear factor-κB; NO = nitric oxide; RT-PCR = reverse transcriptase polymerase chain 
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dial energetics and intracellular calcium handing [8]. In
humans there is a clear relationship between TNF-α expres-
sion in the myocardium and the severity of dilated cardiomyop-
athy [9,10].
The nuclear factor-κB (NF-κB) family of nuclear transcription
factors is critical for the synthesis of TNF-α and for TNF-α
induced secondary mediators of inflammation, such as induci-
ble nitric oxide synthase (iNOS) and cyclo-oxygenase (COX)-
2 [11]. Inflammatory stimuli lead to activation of NF-κB by
inducing the phosphorylation of its inhibitory protein IκB,
allowing its translocation into the nucleus [11-13]. Activating
protein (AP)-1 is another major transcription factor for many
inflammatory mediators, including TNF-α. It comprises a family
of related transcription factors, consisting of heterodimers and
homodimers of Jun, Fos and activating transcription factor
[14]. AP-1 activity is regulated through interactions with extra-
cellular and intracellular signals including p38 mitogen-acti-
vated protein kinase (MAPK), with phosphorylation of
activating transcription factor-2 [14], which leads to expres-
sion of TNF-α [15].
Upon activation of NF-κB and AP-1 by inflammatory stimuli,
expression of inflammatory genes such as that encoding TNF-
α and of proinflammatory enzymes such as iNOS and COX-2
takes place. In the myocardium, activation of NF-κB, p38
MAPK and AP-1 causes myocardial cell damage resulting
from TNF-α production [16-18] and it contributes to perfusion
maldistribution and to myocardial damage by nitric oxide and
eicosanoids, caused by the activity of iNOS and COX-2,
respectively [19].
Our previous experimental studies showed that moderate
hypothermia during cardiac surgery involving CPB is related to
repression of TNF-α, and that this is related to increased syn-
thesis of interleukin-10 in myocardium [2,20]. In the present
study we investigated the signalling pathways involved in this
repression and found that the use of moderate hypothermia is
associated with the inhibition of the p38-MAPK/AP-1 pathway
but not with inhibition of the NF-κB pathway.
Materials and methods
Animals
The study was approved by the supervising state agency for
animal experiments. Twelve stress-resistant female pigs (deut-
sche Landrasse) weighing 40.3 ± 1.4 kg (mean ± standard
deviation) were included. The animals were housed in the insti-
tute for animal experimentation located in our university hospi-
tal for at least 8 days before experiments were begun; this was
to guarantee quiet care before scheduled cardiac surgery.
After clinical veterinary examination was conducted, which
confirmed that the animals were in good health, the pigs were
randomly assigned to a temperature group during CPB (six
pigs in each group): moderate hypothermia (28°C) and normo-
thermia (37°C). Core temperature was monitored using an
oesophageal probe (probe 1651; Datex-Ohmeda Division,
Instrumentarium Corp., Helsinki, Finland).
Surgical procedure
General anaesthesia, and operative and CPB technique were
as previously described [2]. Briefly, following sternotomy,
cephotiam (50 mg/kg intravenously) and heparin were admin-
istered, and both caval veins, the aorta and the left atrium were
cannulated and total CPB instituted for 120 minutes in all ani-
mals. This included 30 minutes perfusion during which animals
subjected to moderate hypothermia during the operation were
cooled down to 28°C; 60 minutes of perfusion during which
the aorta was cross-clamped and right atriotomy performed;
and 30 minutes of perfusion during which pigs undergoing
hypothermic CPB were rewarmed to 37°C. In animals sub-
jected to normothermia during the operation, perfusion was
performed at 37°C for the 120 minutes. CPB was conducted
with a flow index of 2.7 l/(minute. m2 body surface area) in all
animals, with a target mean systemic arterial pressure of 60
Table 1
Oesophageal and myocardial temperatures before, during, and after CPB in pigs operated on under moderate hypothermia or 
normothermia
Time point Esophageal temperature Myocardial temperature
Hypothermia 
(28°C)
Normothermia 
(37°C)
P Hypothermia 
(28°C)
Normothermia 
(37°C)
P
Before CPB 35.9 ± 0.5 36.1 ± 0.9 NS 35.8 ± 0.6 35.7 ± 1.5 NS
10 minutes after institution of CPB 30.1 ± 4.4 36.7 ± 0.4 0.01 28.2 ± 0.4 36.4 ± 1.0 0.001
10 minutes after aortic cross clamping 28.1 ± 0.09 36.6 ± 0.6 0.001 17.2 ± 3.4 17.4 ± 2.4 NS
60 minutes after aortic cross clamping 33.3 ± 1.7 36.2 ± 0.3 0.05 28.1 ± 2.5 31.5 ± 1.5 NS
End of CPB 35.0 ± 1.9 36.6 ± 0.3 NS 34.8 ± 0.5 35.9 ± 1.0 NS
6 hours after CPB 36.1 ± 0.8 38.0 ± 0.5 0.005 36.4 ± 1.1 38.6 ± 0.6 NS
Results are expressed as mean ± standard deviation. CPB, cardiopulmonary bypass; NS, not significant.Available online http://ccforum.com/content/10/2/R57
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mmHg. Immediately after aortic cross-clamping, cardioplegia
was achieved by a single injection of cold (4°C) cardioplegic
solution (Bretschneider solution; 30 ml/kg) into the aortic root.
Additional topical cooling of the myocardium was performed
by application of 500 ml cold (4°C) saline solution. Myocardial
temperature during CPB was monitored using a needle probe
placed into the ventricular septum (Temperature Sensing
Catheter; Medtronic Hemotec. Inc, Englewood, CO, USA). At
the end of CPB, anticoagulation was reversed with protamine,
mediastinal drains were placed and the chest was closed.
Postoperative care
The lungs of the pigs were mechanically ventilated until the
end of the experiment. Postoperative monitoring included con-
tinuous registration of heart rate and rhythm, mean arterial
blood pressure, left atrial pressure, oesophageal temperature
and urine output, and measurement of arterial lactate levels
and blood gases. Animals received dopamine and Ringer's
lactate to optimize hemodynamics. Six hours after sternal clo-
sure the pigs were killed by phenobarbital overdose.
Tissue sampling
Samples for RT-PCR, Western blot and electrophoretic mobil-
ity shift assay were rapidly excised from the apex of the right
ventricle before CPB, before aortic cross-clamping, before
opening the aorta and immediately after death. Samples were
snap frozen in liquid nitrogen and stored at -70°C.
Reverse transcriptase polymerase chain reaction
Total RNA was extracted using Rneasy Mini Kit (QIAGEN Inc.,
Hilden, Germany). RNA (3 µg) was reverse transcribed to
cDNA using random hexamers. Using specific porcine primers
for TNF-α and β-actin, cDNA products were coamplified by
PCR as previously reported [2]. The PCR products were sub-
jected to electrophoresis in 1.8% agarose gel, stained with
ethidium bromide and photographed. The predicted lengths of
amplification products for TNF-α and β-actin were 372 and
233 base pairs, respectively. Results are presented as ratio of
band intensities of the mRNA of TNF-α to the corresponding
β-actin mRNA (Quantity One® Quantification software 4.1;
Bio-Rad: BioRad Laboratories, Inc., Hercules, CA, USA).
Western blot
The samples (100 µg) were treated with SDS-PAGE sample
buffer, followed by heating, and were then subjected to 8% or
12% gels. Western blots were performed with antibodies
against polyclonal goat anti-human TNF-α (DPC Biermann
GmbH, Bad Nauheim, Germany), monoclonal mouse anti-
human iNOS (BD Transduction Laboratories, Heidelberg,
Germany), polyclonal rabbit anti-human COX-2 (Alexis Deut-
Figure 1
TNF-α mRNA expression and TNF-α concentration: hypothermia versus normothermia TNF-α mRNA expression and TNF-α concentration: hypothermia versus normothermia. Shown are the expression of TNF-α mRNA and TNF-α con-
centrations in pigs operated on under moderate hypothermia (28°C; circles) or normothermia (37°C; squares). The time points of evaluation were as 
follows: 1 = before CPB; 2 = before aortic cross clamping; 3 = before removal of aortic clamp; and 4 = 6 hours after CPB. (a) In the upper panel, 
showing TNF-α mRNA findings, results are given as mean ± standard deviation. §P < 0.1. Lower panel: gel showing the effect of temperature on 
myocardial expression of TNF-α mRNA; results are representative of six independent experiments in each group. (b) In the upper panel, showing 
TNF-α protein concentrations, results are given as mean ± standard deviation. *P < 0.05, §P < 0.1. Lower panel: gel showing the effect of tempera-
ture on myocardial expression of TNF-α, as detected by Western blot. Band intensities for TNF-α were normalized for band intensities for actin. 
Results are representative of six independent experiments in each group (28°C = hypothermia, 37°C = normothermia). bp, base pairs; CPB cardiop-
ulmonary bypass; M, molecular weight markers; TNF, tumour necrosis factor.Critical Care    Vol 10 No 2    Qing et al.
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schland GmbH, Grünberg, Germany), monoclonal mouse anti-
human phospho-IκB-α (Ser32/36), polyclonal rabbit anti-
human phospho-p38 MAPK and p38 MAPK (Cell Signalling
Technology, Inc., Frankfurt am Main, Germany), and polyclonal
goat anti-human actin (DAKO, Glostrup, Denmark). The bands
were detected using a chemiluminescent system. Restaining
with actin antibody ensured equal loading. Band intensities of
TNF-α, iNOS, COX-2 and phospho-IκB-α were normalized to
that of actin, and those of phospho-p38 MAPK were normal-
ized to that of p-38 MAPK (Quantity One® Quantification soft-
ware 4.1; Bio-Rad).
For measurement of the concentrations of phospho-c-Jun and
c-Jun, nuclear extracts (20 µg) were treated with SDS-PAGE
sample buffer, followed by heating, and were then subjected
to 10% gels. Western blots were performed with antibodies
against monoclonal mouse anti-human phospho-c-Jun and
polyclonal rabbit anti-human c-Jun (both Santa Cruz Biotech-
nology, Heidelberg, Germany) and polyclonal goat anti-human
actin (DAKO). The bands were detected using a chemilumi-
nescent system. Restaining with actin antibody ensured equal
loading. Band intensities of phospho-c-Jun and c-Jun were
normalized to that of actin (Quantity One® Quantification soft-
ware 4.1; Bio-Rad).
Electrophoretic mobility shift assay
Nuclear extracts were prepared as previously described [21].
Protein concentrations were determined using a Bio-Rad pro-
tein assay. The electrophoretic mobility shift assay was per-
formed using a double-stranded 32P-labelled mutated sis-
inducible element oligonucleotide from NF-κB (5'-AGT TGA
GGG GAC TTT CC-3') and using a double-stranded 32P-
labelled consensus oligonucleotide from AP-1 (5'-CGC TTG
ATG ACT CAG CCG GAA-3'; both MWG-Biotech AG, Eber-
sberg, Germany). For supershift assays, nuclear extracts were
incubated with antibodies against NF-κB p50 and NF-κB p65
subunits and AP-1 c-Jun subunit (all polyclonal rabbit anti-
human; Santa Cruz Biotechnology) for 30 minutes at room
temperature before addition of the radiolabelled probe. The
protein/DNA complexes were separated on a 6% polyacryla-
mide gel containing 7.5% glycerol in 0.25-fold tuberculin bac-
illary emulsion (20 mmol/l Tris, 20 mmol/l boric acid, 0.5 mmol/
l EDTA) at 210 V for 3 hours. Gels were dried and autoradio-
graphed. Positive controls for AP-1 were performed on human
HepG2 stimulated by TNF-α 10 ng/ml for 4 hours.
Statistical analysis
Results are expressed as mean ± standard deviation. Data
were analyzed by analysis of variance with adjustment of P val-
ues by the t  test. Differences between time points within
groups were calculated using paired t tests using the Statisti-
cal Package for Social Sciences (SPSS; SPSS Software
GmbH, Munich, Germany).
Results
Oesophageal and myocardial temperatures
Oesophageal temperature during and after CPB was signifi-
cantly lower in animals operated on under hypothermia than in
the other animals. In contrast, myocardial temperature during
CPB did not differ significantly between groups, with the
exception of that measured before cross-clamping of the aorta
(Table 1).
Haemodynamics and lactate levels
Heart rate, mean arterial and left and right atrial pressures,
cathecolamine support and urine output were not significantly
different between groups (data not shown). Lactate levels
were lower at the end of CPB in animals operated on under
moderate hypothermia than in the other animals (4.8 ± 0.3 mg/
ml versus 6.9 ± 0.3 mg/ml; P < 0.002).
Myocardial expression of tumour necrosis factor-α
There was no TNF-α expression before institution of CPB;
however, there was expression 30 min after establishing CPB
and before cross-clamping of the aorta. At that time, both TNF-
α gene expression and TNF-α concentrations tended to be
Table 2
Intramyocardial DNA binding activity of NF-κB and synthesis of inflammatory mediators before, during, and after CPB in pigs 
operated on under moderate hypothermia or normothermia
Parameter Before CPB Before aortic cross clamping Before removal of aortic 
clamp
6 hours after CPB
28°C 37°C 28°C 37°C 28°C 37°C 28°C 37°C
Activity of NF-κB 
(count/mm2)
400.8 ± 14.3 439.2 ± 63.3 696.4 ± 25.9 555.1 ± 32.1 643.5 ± 7.45 507.3 ± 9.22 676.3 ± 12.8 611.0 ± 98.7
Phospho-IκB-α 0.18 ± 0.32 0.24 ± 0.45 0.71 ± 1.13 0.70 ± 0.87 0.72 ± 0.96 0.64 ± 0.49 0.85 ± 0.59 0.66 ± 0.43
iNOS 0.00 ± 0.00 0.00 ± 0.00 0.47 ± 0.54 0.29 ± 0.55 0.58 ± 0.97 0.48 ± 0.40 0.88 ± 0.58 0.47 ± 0.48
COX-2 0.09 ± 0.1 0.11 ± 0.08 0.16 ± 0.09 0.50 ± 0.18* 0.54 ± 0.06 0.68 ± 0.33 0.25 ± 0.26 0.47 ± 0.13
Results (mean ± standard deviation) are shown as the ratio of protein levels of phospho-IκB-α, iNOS and COX-2 to actin. *P < 0.05 between 
groups. COX, cyclooxygenase-2; CPB, cardiopulmonary bypass; iNOS, inducible nitric oxide synthase; NF-κB, nuclear factor-κB; phospho-IκB-α, 
phosphorylation of inhibitor of NF-κB α.Available online http://ccforum.com/content/10/2/R57
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lower in pigs operated on under moderate hypothermia than in
the other animals (Figure 1a,b). Six hours after CPB, concen-
trations of TNF-α were lower in animals operated on under
moderate hypothermia than in the others (P < 0.05; Figure
1a,b).
Activation of nuclear factor-κB
There was weak DNA binding activity of NF-κB before CPB
that increased during and after CPB similarly in both animal
groups (Table 2). The supershift experiment showed that the
NF-κB DNA binding complex containing p50 and p65 was
already present before CPB (Figure 2a,b). Phosphorylation of
IκB-α in the myocardium paralleled DNA binding activity of NF-
κB before, during and after CPB in both animal groups (Table
2).
Phosphorylation of p38 mitogen-activated protein 
kinase
There was weak phosphorylation of p38 MAPK before CPB in
all animals. In those operated on under hypothermia, levels of
phospho-p38 MAPK were lower during and after CPB than in
animals operated on under normothermic conditions. In the lat-
ter animals, levels of phospho-p38 MAPK increased as soon
as 30 minutes after CPB was established and reached a peak
value just before removal of the aortic clamp (1 hour after
ischaemia), and then decreased by 6 hours after CPB. Ani-
mals operated on under hypothermia exhibited lower levels of
phospho-p38 MAPK 30 minutes after establishing CPB as
compared with the other animals (P < 0.05; Figure 3a). Levels
of phospho-c-Jun detected in the nuclear extract paralleled the
activation of p38 MAPK in all animals during CPB, but contin-
ued to increase after CPB exclusively in those subjected to
normothermia. In the other animals, levels of phospho-c-Jun
were lower after removal of the aortic clamp and 6 hours after
CPB (P < 0.05; Figure 3b).
Activation of activating protein-1
There was weak DNA binding activity of AP-1 before CPB in
all animals. In animals operated on under hypothermia, AP-1
activity was lower during and after CPB than in those operated
on under normothermia. In these latter animals, the DNA bind-
ing activity of AP-1 increased as soon as 30 minutes after
CPB was established, remaining elevated for up to 6 hours
after CPB (Figure 4a). Animals operated on under hypother-
mia exhibited lower DNA binding activity of AP-1 during and
after CPB as compared with the others (P < 0.05 and P <
0.005, respectively; Figure 4a). The supershift experiment
revealed that the AP-1 DNA binding complex containing c-Jun
was present before and persisted during and after CPB (Fig-
ure 4b).
Synthesis of inducible nitric oxide synthase and cyclo-
oxygenase-2
iNOS was not detected before but 30 minutes after establish-
ing CPB in all animals. Its synthesis increased during and after
CPB without any difference between groups (table 2).
Figure 2
DNA binding activity of NF-κB: hypothermia versus normothermia DNA binding activity of NF-κB: hypothermia versus normothermia. (a) DNA binding activity of NF-κB, as measured by EMSA and confirmed by 
supershift in myocardium, in pigs operated on under moderate hypothermia (28°C; circles) or normothermia (37°C; squares). The time points of eval-
uation were as follows: 1 = before CPB; 2 = before aortic cross clamping; 3 = before removal of aortic clamp; and 4 = 6 hours after CPB. Data are 
expressed as mean ± standard deviation. (b) Example gel showing the effect of temperature during CPB on activation of NF-κB as detected by 
EMSA and confirmed by supershift with anti-p50 and anti-p65 in pigs operated on under hypothermia (28°C) or normothermia (37°C). Results are 
representative of four independent experiments in each group. CNT, counts/mm2; CPB, cardiopulmonary bypass; EMSA, electrophoretic mobility 
shift assay; NF-κB, nuclear factor-κB; NS, nonspecific.Critical Care    Vol 10 No 2    Qing et al.
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COX-2 levels increased during CPB in all animals. At 30 min-
utes after establishing CPB the COX-2 levels in animals oper-
ated on under moderate hypothermia were significantly lower
than in the other animals (P < 0.005; Table 2).
Discussion
This study shows for the first time that the repression of TNF-
α associated with application of moderate hypothermia during
CPB is associated with inhibition of the p38 MAPK/AP-1 path-
way but not that of the NF-κB pathway.
In previous studies we reported that animals operated on
under moderate hypothermic CPB have lower plasma levels
and lower myocardial concentrations of TNF-α as well as less
organ damage than do animals operated on under normother-
mic conditions [2,20]. In the present study we found that the
anti-inflammatory effects of moderate hypothermia with
repression of TNF-α and of its secondary mediator COX-2 are
present as early as 30 minutes after initiation of CPB. This
observation is supported by other investigators [22], who
reported repression of TNF-α by hypothermia during ischae-
mia and early reperfusion periods in the liver.
The main aim of this work was to identify the upstream mech-
anisms that regulate the expression of TNF-α and COX-2, lev-
els of which appear to be reduced by hypothermia. We
therefore investigated both of the main signalling pathways
involved in the expression of inflammatory mediators, namely
the NF-κB [11] and AP-1 [23] pathways, and observed a dif-
ferential effect of hypothermia on those transcription factors.
Indeed, although in our series hypothermia led to reductions in
phosphorylation of p38 MAPK and AP-1 activation, it did not
affect activation of NF-κB in the myocardium. This confirms
our previous work showing that hypothermia does not inhibit
NF-κB activation in liver [21].
The inhibitory effect of hypothermia on p38 MAPK that we
report here is supported by experimental work conducted in
rat fibroblasts that showed inhibition of Raf [24], a mitogen-
stimulated protein kinase that is an important intermediate to
p38 MAPK activation by cold stress [25]. Via inhibition of Raf,
hypothermia suppresses the phosphorylation of p38 MAPK in
vitro, thereby inhibiting phosphorylation of c-Jun and AP-1 acti-
vation [22].
Regulation of the activity of AP-1 occurs at two levels, depend-
ing on its concentrations and on the level of its phosphoryla-
tion [26]. In the present study, there was no difference in levels
of c-Jun in nuclear extract between the groups, but animals
operated on in hypothermia exhibited lower phosphorylation of
Figure 3
Activation of p38 MAPK and c-Jun: hypothermia versus normothermia Activation of p38 MAPK and c-Jun: hypothermia versus normothermia. Shown is activation of p38 MAPK (phospho-p38 MAPK) and c-Jun (phospho-
c-Jun) in myocardium of pigs operated on under moderate hypothermia (28°C; circles) or under normothermia (37°C; squares). The time points of 
evaluation were as follows: 1 = before CPB; 2 = before aortic cross clamping; 3 = before removal of aortic clamp; and 4 = 6 hours after CPB. (a) In 
the upper panel, showing phospho-p38 MAPK findings, results are given as mean ± standard deviation. *P < 0.05. Band intensities for phospho-
p38 MAPK were normalized for band intensities of total p38 MAPK. Lower panel: gel showing the effect of temperature on myocardial expression of 
phospho-p38 MAPK detected by Western blot. Results are representative of six independent experiments in each group. (b) In the upper panel, 
showing phospho-c-Jun findings, results are given as mean ± standard deviation. *P < 0.02. Band intensities for phospho-c-Jun were normalized for 
band intensities of actin. Lower panel: gel showing the effect of temperature on expression of phospho-c-Jun in the nuclear extract detected by 
Western blot. Results are representative of four independent experiments in each group (28°C = moderate hypothermia; 37°C = normothermia). 
CPB, cardiopulmonary bypass; MAPK, mitogen-activated protein kinase.Available online http://ccforum.com/content/10/2/R57
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c-Jun and lower DNA binding activity of AP-1 during and after
CPB than did those operated on in normothermia. Therefore,
we suggest that hypothermia during CPB inhibits phosphor-
ylation of p38 MAPK, which in turn suppresses its nuclear tar-
gets, namely phosphorylation of c-Jun and activation of the
transcription factor AP-1.
The clinical relevance of NF-κB and p38 MAPK/AP-1 activa-
tion in myocardium has been pointed out by several studies
suggesting that both pathways are important actors in the fail-
ing heart [18,27]. NF-κB plays a central role in the myocardial
inflammatory response, including TNF-α secretion by cardio-
myocytes in response to systemic endotoxin [28]. However,
NF-κB activation is also necessary for later preconditioning of
the myocardium, and thus a potential role of this transcription
factor for myocardial protection has been suggested [11]. The
important role played by p38 MAPK/AP-1 in the myocardial
inflammatory response is widely recognized [18,23]. Indeed,
p38 MAPK activation is sufficient to induce inflammatory
cytokine expression including TNF-α in cardiomyocytes in vitro
and in vivo [18]. A recent study [18] showed that the inhibition
of p38 MAPK activities blocks TNF-α secretion in transgenic
hearts. The congruency of the effect of moderate hypothermia
on phosphorylation of p38 MAPK and activity of AP-1, and on
expression of TNF-α suggests that, in our model, moderate
hypothermia during CPB represses the expression of TNF-α in
the myocardium by selective inhibition of the p38 MAPK/AP-1
pathway.
In a similar in vivo model, we previously showed that hypother-
mia during CPB confers myocardial protection by inhibiting
intramyocardial expression of TNF-α [2,20]. Cardiodepressive
effects of TNF-α have been ascribed to immediate negative
inotropic effects on cardiomyocytes mediated by sphyngo-
sine, independent of NO, and to delayed NO-dependent neg-
ative inotropic effects [29]. High local concentrations of NO
related to induction of iNOS are associated with myocardial
cell damage and cell death [30]. In the present study, hypo-
thermia during CPB did not inhibit synthesis of iNOS in myo-
cardium despite repression of TNF-α. That expression of iNOS
in cultured cardiac myocytes does not increase in response to
TNF-α and that TNF-α does not influence iNOS mRNA expres-
sion and NO release in the isolated rat heart [31-33] supports
our observation. In addition, endotoxin-induced TNF-α
depresses myocardial contractility of isolated rat hearts inde-
pendent of NO synthesis [34].
COX-2 is upregulated by various factors, including TNF-α, via
the transcription factors NF-κB and AP-1 [11,35]. The latter is
the major promotor element involved in COX-2 expression in
cardiomyocytes [36]. Significant expression of COX-2 has
been demonstrated in the myocardium of patients with con-
gestive heart failure and in rat heart after treatment with endo-
toxin [37,38]. In our series expression of COX-2 paralleled the
expression of TNF-α and activation of AP-1 during and after
CPB, suggesting that COX-2 expression was mediated by
TNF-α through AP-1. Myocardial depression in isolated rat
hearts in response to staphylococcal α-toxin results from
COX-2 derived thromboxane A2 liberation, leading to coronary
vasconstriction and perfusion mismatch [39,40]. In the
present study, animals operated on under hypothermia did not
differ from the other animals with respect to haemodynamics,
Figure 4
DNA binding activity of AP-1: hypothermia versus normothermia DNA binding activity of AP-1: hypothermia versus normothermia. (a) DNA-binding activity of AP-1, as measured by EMSA and confirmed by super-
shift in the myocardium, in pigs operated on under moderate hypothermia (28°C; circles) or normothermia (37°C; squares). The time points of evalu-
ation were as follows: 1 = before CPB; 2 = before aortic cross clamping; 3 = before removal of aortic clamp; and 4 = 6 hours after CPB. Data are 
expressed as mean ± standard deviation. §P < 0.1, **P < 0.05, versus prebypass value in normothermia group; §P < 0.1, *P < 0.05 between both 
groups. (b) Example gel showing the effect of temperature during CPB on activation of AP-1, as detected by EMSA and confirmed by supershift, 
with anti-c-Jun antibody in pigs operated on under hypothermia (28°C) or normothermia (37°C). Results are representative of four independent 
experiments in each group. AP, activating protein; CNT, count/mm2; CPB, cardiopulmonary bypass; EMSA, electrophoretic mobility shift assay; NS, 
nonspecific; PC, positive control.Critical Care    Vol 10 No 2    Qing et al.
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but the fact that they had lower levels of lactate than did the
pigs operated on under normothermia indicates that they had
better tissue perfusion.
Conclusion
Our findings suggest that myocardial repression of TNF-α and
COX-2 related to moderate hypothermia during CPB is due to
inhibition of the p38 MAPK/AP-1 pathway but not that of NF-
κB.
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